Multicohort Study of Conditional Survival and Cause of Death After Achieving Event-Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)

被引：0
|
作者：
Wang, Yucai [1 ]
Larson, Melissa [1 ]
Ekberg, Sara [2 ]
Smedby, Karin [2 ]
Zhao, Eric [3 ]
Gerrie, Alina [3 ]
Farooq, Umar [4 ]
Maurer, Matthew [1 ]
Paludo, Jonas [1 ]
Nowakowski, Grzegorz [1 ]
Habermann, Thomas [1 ]
Albertsson-Lindblad, Alexandra [5 ]
Glimelius, Ingrid [6 ]
Link, Brian [4 ]
Villa, Diego [3 ]
Jerkeman, Mats [5 ]
Cerhan, James [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Karolinska Inst, Stockholm, Sweden
[3] BC Canc, Vancouver, BC, Canada
[4] Univ Iowa, Iowa City, IA USA
[5] Lund Univ, Lund, Sweden
[6] Uppsala Univ, Uppsala, Sweden
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
mantle cell lymphoma; event-free survival at 24 months (EFS24); overall survival; cause of death;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MCL-063
引用
收藏
页码：S457 / S458
页数：2
相关论文
共 50 条
  • [31] Progression Free Survival at 24 Months in Patients with Diffuse Large B-Cell Lymphoma, an Argentinian Retrospective Cohort Study
    Warley, Fernando
    Cristaldo, Nancy
    Colucci, Giuliana
    Otero, Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S290 - S291
  • [32] The skin microbiome stratifies patients with cutaneous T cell lymphoma and determines event-free survival
    Licht, Philipp
    Dominelli, Nazzareno
    Kleemann, Johannes
    Pastore, Stefan
    Mueller, Elena-Sophia
    Haist, Maximilian
    Hartmann, Kim Sophie
    Stege, Henner
    Bros, Matthias
    Meissner, Markus
    Grabbe, Stephan
    Heermann, Ralf
    Mailaender, Volker
    NPJ BIOFILMS AND MICROBIOMES, 2024, 10 (01)
  • [33] Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
    Yong Yang
    Ying Wang
    Xin Liu
    Xia He
    Li-Ling Zhang
    Gang Wu
    Bao-Lin Qu
    Li-Ting Qian
    Xiao-Rong Hou
    Fu-Quan Zhang
    Xue-Ying Qiao
    Hua Wang
    Gao-Feng Li
    Yuan Zhu
    Jian-Zhong Cao
    Jun-Xin Wu
    Tao Wu
    Su-Yu Zhu
    Mei Shi
    Li-Ming Xu
    Hang Su
    Yu-Qin Song
    Jun Zhu
    Yu-Jing Zhang
    Hui-Qiang Huang
    Chen Hu
    Shu-Nan Qi
    Ye-Xiong Li
    Leukemia, 2021, 35 : 2736 - 2737
  • [34] Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months A Single Institutional Study
    Ali, Nadia D.
    Donohue, Kristen
    Zandieh, Shadi
    Chen, Chunxia
    Moore, Dirk
    Poplin, Elizabeth
    Shah, Mihir M.
    Nosher, John
    Gui, Bin
    Jabbour, Salma K.
    Spencer, Kristen
    Carpizo, Darren R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (06): : 512 - 518
  • [35] Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review
    Jie Zhu
    Yong Yang
    Jin Tao
    Shu-Lian Wang
    Bo Chen
    Jian-Rong Dai
    Chen Hu
    Shu-Nan Qi
    Ye-Xiong Li
    Leukemia, 2020, 34 : 2576 - 2591
  • [36] Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review
    Zhu, Jie
    Yang, Yong
    Tao, Jin
    Wang, Shu-Lian
    Chen, Bo
    Dai, Jian-Rong
    Hu, Chen
    Qi, Shu-Nan
    Li, Ye-Xiong
    LEUKEMIA, 2020, 34 (10) : 2576 - 2591
  • [37] Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population
    Shirouchi, Yuko
    Yokoyama, Masahiro
    Fukuta, Takanori
    Uryu, Hideki
    Nishimura, Noriko
    Mishima, Yuko
    Inoue, Norihito
    Tsuyama, Naoko
    Takeuchi, Kengo
    Terui, Yasuhito
    LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 1869 - 1876
  • [38] High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)
    T E Witzig
    B LaPlant
    T M Habermann
    E McPhail
    D J Inwards
    I N Micallef
    J P Colgan
    G S Nowakowski
    S M Ansell
    P B Johnston
    Blood Cancer Journal, 2017, 7 (6) : e576 - e576
  • [39] High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)
    Witzig, T. E.
    LaPlant, B.
    Habermann, T. M.
    McPhail, E.
    Inwards, D. J.
    Micallef, I. N.
    Colgan, J. P.
    Nowakowski, G. S.
    Ansell, S. M.
    Johnston, P. B.
    BLOOD CANCER JOURNAL, 2017, 7
  • [40] Overall and event-free survival of childhood lymphoma in Greece: analysis of harmonized clinical data over a 24-year active registration period
    Karalexi, Maria A.
    Pourtsidis, Apostolos
    Panagopoulou, Paraskevi
    Moschovi, Maria
    Polychronopoulou, Sophia
    Kourti, Maria
    Hatzipantelis, Emmanuel
    Stiakaki, Eftichia
    Dana, Helen
    Bouka, Panagiota
    Ntzani, Evangelia E.
    Petridou, Eleni Th.
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2107 - 2119
12345